Search research articles
Contact Us
Filters
Showing results (1-10 of 117) with videos related to
Page
of 12
Sort By:
British Journal of Cancer
|
April 2, 2020
Comment on: "Exploring the best treatment options for BRAF-mutant metastatic colon cancer"
Gérard Milano, Jocelyn Gal
Computer Methods and Programs in Biomedicine
|
March 13, 2012
Designing group sequential randomized clinical trials with time to event end points using a R function
Thomas Filleron, Jocelyn Gal, Andrew Kramar
Current Opinion in Oncology
|
March 5, 2024
Molecular and nutritional markers in head and neck cancer
Gerard Milano, Jocelyn Gal, René-Jean Bensadoun
Future Virology
|
December 10, 2021
Myocarditis and COVID-19 mRNA vaccines: a mechanistic hypothesis involving dsRNA
Gerard Milano, Jocelyn Gal, Anne Creisson, et al.
International Journal of Molecular Sciences
|
July 12, 2025
PD-L1 Expression in NSCLC: Clouds in a Bright Sky
Victoria Ferrari, Jocelyn Gal, Baharia Mograbi, et al.
International Journal of Molecular Sciences
|
September 28, 2024
Companion Tests and Personalized Cancer Therapy: Reaching a Glass Ceiling
Victoria Ferrari, Baharia Mograbi, Jocelyn Gal, et al.
Pharmaceuticals (Basel, Switzerland)
|
July 27, 2024
Critical Appraisal and Future Challenges of Artificial Intelligence and Anticancer Drug Development
Emmanuel Chamorey, Jocelyn Gal, Baharia Mograbi, et al.
Critical Reviews in Oncology/Hematology
|
July 14, 2019
Germinal immunogenetics as a predictive factor for immunotherapy
Sadal Refae, Jocelyn Gal, Patrick Brest, et al.
Cancers
|
August 14, 2025
De-Escalating Anticancer Treatment: Watch Your Step
Jean-Marc Ferrero, Rym Bouriga, Jocelyn Gal, et al.
Pharmaceuticals (Basel, Switzerland)
|
September 27, 2025
PROTACs and Glues: Striking Perspectives for Engineering Cancer Therapy À La Carte
Jean-Marc Ferrero, Jocelyn Gal, Baharia Mograbi, et al.
Page
of 12
Search research articles
Search
Showing results (1-10 of 117) with videos related to
Sort By:
Page
of 12
British Journal of Cancer
|
April 2, 2020
Comment on: "Exploring the best treatment options for BRAF-mutant metastatic colon cancer"
Gérard Milano, Jocelyn Gal
Computer Methods and Programs in Biomedicine
|
March 13, 2012
Designing group sequential randomized clinical trials with time to event end points using a R function
Thomas Filleron, Jocelyn Gal, Andrew Kramar
Current Opinion in Oncology
|
March 5, 2024
Molecular and nutritional markers in head and neck cancer
Gerard Milano, Jocelyn Gal, René-Jean Bensadoun
Future Virology
|
December 10, 2021
Myocarditis and COVID-19 mRNA vaccines: a mechanistic hypothesis involving dsRNA
Gerard Milano, Jocelyn Gal, Anne Creisson, et al.
International Journal of Molecular Sciences
|
July 12, 2025
PD-L1 Expression in NSCLC: Clouds in a Bright Sky
Victoria Ferrari, Jocelyn Gal, Baharia Mograbi, et al.
International Journal of Molecular Sciences
|
September 28, 2024
Companion Tests and Personalized Cancer Therapy: Reaching a Glass Ceiling
Victoria Ferrari, Baharia Mograbi, Jocelyn Gal, et al.
Pharmaceuticals (Basel, Switzerland)
|
July 27, 2024
Critical Appraisal and Future Challenges of Artificial Intelligence and Anticancer Drug Development
Emmanuel Chamorey, Jocelyn Gal, Baharia Mograbi, et al.
Critical Reviews in Oncology/Hematology
|
July 14, 2019
Germinal immunogenetics as a predictive factor for immunotherapy
Sadal Refae, Jocelyn Gal, Patrick Brest, et al.
Cancers
|
August 14, 2025
De-Escalating Anticancer Treatment: Watch Your Step
Jean-Marc Ferrero, Rym Bouriga, Jocelyn Gal, et al.
Pharmaceuticals (Basel, Switzerland)
|
September 27, 2025
PROTACs and Glues: Striking Perspectives for Engineering Cancer Therapy À La Carte
Jean-Marc Ferrero, Jocelyn Gal, Baharia Mograbi, et al.
Page
of 12